ArticleJournal of clinical & translational endocrinology2023

Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes.

Fabian Lurquin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.